Growth Metrics

Baxter International (BAX) Accumulated Expenses (2016 - 2025)

Baxter International (BAX) has disclosed Accumulated Expenses for 16 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 5.75% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 5.75% increase, with the full-year FY2025 number at $2.0 billion, up 5.75% from a year prior.
  • Accumulated Expenses was $2.0 billion for Q4 2025 at Baxter International, up from $1.9 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.5 billion in Q4 2021 to a low of $1.8 billion in Q1 2021.
  • A 5-year average of $2.1 billion and a median of $2.2 billion in 2022 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 31.58% in 2021, then dropped 12.46% in 2022.
  • Baxter International's Accumulated Expenses stood at $2.5 billion in 2021, then dropped by 12.46% to $2.2 billion in 2022, then fell by 11.75% to $1.9 billion in 2023, then decreased by 2.82% to $1.9 billion in 2024, then grew by 5.75% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BAX's Accumulated Expenses are $2.0 billion (Q4 2025), $1.9 billion (Q4 2024), and $1.8 billion (Q3 2024).